Huijuan Song
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Huijuan Song has a total of 89 co-authors. Here are the top co-authors by number of shared publications:
- Weiwei Wang
College of Life Sciences, Key Laboratory of Bioactive Materials (Ministry of Education), State Key Laboratory of Medicinal Chemical Biology, Nankai University, Tianjin, 300071, China
8 shared publications - Jinfeng Xing
School of Chemical Engineering and Technology, Tianjin University, Tianjin, China
7 shared publications - Qiang Liu
Institute of Radiation Medicine, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China
7 shared publications Fangzheng Zhao
School of Chemical Engineering and Technology
6 shared publicationsTong Wu
School of Chemical Engineering and Technology
6 shared publicationsChunyue Zhao
School of Chemical Engineering and Technology
5 shared publications
Latest Publications
- 15 January 2026
- Published by American Chemical Society (ACS) in ACS Nano
- Vol. 20 (3) , 2842-2855
An Ultrasonic Probe-Fabricated Nanocapsule for Cytomembrane-Anchoring Photodynamic Therapy and In Situ Tumor Vaccine
Lipopolysaccharide (LPS) is recognized as a promising candidate for immunotherapy due to its potent immunogenic properties. However, this strong immunogenicity necessitates precise and protective delivery strategies to ensure safe and effective application. In this study, an ultrasonic probe-fabricated nanocapsule was first developed. Owing to the hydrophobic barrier provided by the system, LPS covalently linked methyl acrylated hyaluronic acid (HAMA-LPS) based surfactant-free emulsion polymerization occurred exclusively at the interface of monomer vesicles, resulting in the formation of a hollow-structured nanocapsule. This structure not only protected the immunogenic LPS from oxidative damage in free radical polymerization but also enabled the in situ loading of the hydrophobic photosensitizer chlorin e6 (Ce6). The prepared nanocapsules achieved a 1.53% loading rate of Ce6 and could effectively generate ROS under laser irradiation and undergo acid/enzyme-responsive release. Following cellular uptake by tumor cells, the nanocapsule underwent degradation mediated by hyaluronidase, leading to the release of LPS-Ce6. Subsequently, LPS-Ce6 anchored onto the tumor cell membrane via hydrophobic interactions and exerted photodynamic therapy upon laser irradiation. This therapeutic strategy elicited a robust immune response. On the one hand, photodynamic therapy compromised cell membrane integrity, thereby promoting the release of damage-associated molecular patterns. More importantly, the membrane-anchored LPS-Ce6 acted as an in situ antitumor vaccine, providing a focal point for monocyte and macrophage recruitment, while inducing macrophage polarization toward the M1 phenotype and stimulating the secretion of various antitumor cytokines. Both in vitro and in vivo experimental results demonstrated that the nanocapsule effectively inhibited tumor growth and generated a significant antitumor immune response.
- 15 January 2026
- Published by American Chemical Society (ACS) in ACS Nano
- Vol. 20 (3) , 2842-2855
An Ultrasonic Probe-Fabricated Nanocapsule for Cytomembrane-Anchoring Photodynamic Therapy and In Situ Tumor Vaccine
Lipopolysaccharide (LPS) is recognized as a promising candidate for immunotherapy due to its potent immunogenic properties. However, this strong immunogenicity necessitates precise and protective delivery strategies to ensure safe and effective application. In this study, an ultrasonic probe-fabricated nanocapsule was first developed. Owing to the hydrophobic barrier provided by the system, LPS covalently linked methyl acrylated hyaluronic acid (HAMA-LPS) based surfactant-free emulsion polymerization occurred exclusively at the interface of monomer vesicles, resulting in the formation of a hollow-structured nanocapsule. This structure not only protected the immunogenic LPS from oxidative damage in free radical polymerization but also enabled the in situ loading of the hydrophobic photosensitizer chlorin e6 (Ce6). The prepared nanocapsules achieved a 1.53% loading rate of Ce6 and could effectively generate ROS under laser irradiation and undergo acid/enzyme-responsive release. Following cellular uptake by tumor cells, the nanocapsule underwent degradation mediated by hyaluronidase, leading to the release of LPS-Ce6. Subsequently, LPS-Ce6 anchored onto the tumor cell membrane via hydrophobic interactions and exerted photodynamic therapy upon laser irradiation. This therapeutic strategy elicited a robust immune response. On the one hand, photodynamic therapy compromised cell membrane integrity, thereby promoting the release of damage-associated molecular patterns. More importantly, the membrane-anchored LPS-Ce6 acted as an in situ antitumor vaccine, providing a focal point for monocyte and macrophage recruitment, while inducing macrophage polarization toward the M1 phenotype and stimulating the secretion of various antitumor cytokines. Both in vitro and in vivo experimental results demonstrated that the nanocapsule effectively inhibited tumor growth and generated a significant antitumor immune response.
- 27 December 2025
- Published by Elsevier in Journal of Colloid and Interface Science
- Vol. 708, 139797
Skin-inspired biogel/nanofiber composite dressing for sustained co-delivery of asiaticoside and zinc ions enabling synergistic burn wound healing
- 27 December 2025
- Published by Elsevier in Journal of Colloid and Interface Science
- Vol. 708, 139797
Skin-inspired biogel/nanofiber composite dressing for sustained co-delivery of asiaticoside and zinc ions enabling synergistic burn wound healing
- Open Access
- 11 December 2025
- Published by Elsevier in Precision Medicine and Engineering
- Vol. 3 (1)
Advanced hydrogel platforms for inflammatory bowel disease therapy: Smart drug delivery, immunomodulation, and remodeling of the gut microenvironment
- 11 December 2025
- Published by Elsevier in Precision Medicine and Engineering
- Vol. 3 (1)
Open AccessAdvanced hydrogel platforms for inflammatory bowel disease therapy: Smart drug delivery, immunomodulation, and remodeling of the gut microenvironment
- 28 October 2025
- Published by Elsevier in Biomaterials
- Vol. 328, 123804
pH-responsive sparfloxacin/Fe3+ nanoparticles eradicate intratumoral bacteria and activate ferroptosis for enhanced antitumor immunotherapy in breast cancer
- 28 October 2025
- Published by Elsevier in Biomaterials
- Vol. 328, 123804
pH-responsive sparfloxacin/Fe3+ nanoparticles eradicate intratumoral bacteria and activate ferroptosis for enhanced antitumor immunotherapy in breast cancer
- 17 October 2025
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 331, 148346
Chlorophyll hyaluronic acid nanogels for enhanced tumor photodynamic therapy
- 17 October 2025
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 331, 148346
Chlorophyll hyaluronic acid nanogels for enhanced tumor photodynamic therapy
- Open Access
- 24 April 2025
- Published by Wiley in Advanced Science
- Vol. 12 (21) , e2415886
An Off‐the‐Shelf Artificial Proregenerative Macrophage for Pressure Ulcer Treatment
Cell therapy is a promising approach in regenerative medicine. However, maintaining the survival and function of injected or implanted therapeutic cells remains a substantial challenge to success. In vivo modulatory strategy for cell therapeutics has been recently developed, but suffers from limited regenerative efficacy in injured tissue microenvironment with chronic inflammation. Here, an off‐the‐shelf artificial macrophage (artM) assembled by M2 macrophages‐derived lysate proteins‐loaded poly (lactic‐co‐glycolic acid) (PLGA) microspheres coated by macrophage cell membrane is developed. The synthetic artM fabricated in batches maintains its bioactivity with long‐term cryostorage. Significantly, artM recapitulates the essential inflammation‐regulatory and proregenerative characteristics of endogenous macrophages, including initiating M2 macrophage polarization, resolving excessive inflammation by releasing anti‐inflammatory cytokines and growth factors, neutralizing endotoxins and proinflammatory cytokines, augmenting T‐helper 2 (TH2) immune response, and coordinating cell migration and proliferation. In mouse model of deep tissue pressure injury (DTPI), the artM induces tissue regeneration by modulating the inflammatory microenvironment, promoting angiogenesis, reducing scar deposition, and accelerating the renewal of skin appendages. Depletion of macrophages in mice with skin ulcers highlights the immunomodulatory and proangiogenic functions of artM as effective as autogenous macrophages. Collectively, the engineered artM represents a cell‐free, proreparative alternative to immune cell therapy in chronic wound management.
- 24 April 2025
- Published by Wiley in Advanced Science
- Vol. 12 (21) , e2415886
Open AccessAn Off‐the‐Shelf Artificial Proregenerative Macrophage for Pressure Ulcer Treatment
Cell therapy is a promising approach in regenerative medicine. However, maintaining the survival and function of injected or implanted therapeutic cells remains a substantial challenge to success. In vivo modulatory strategy for cell therapeutics has been recently developed, but suffers from limited regenerative efficacy in injured tissue microenvironment with chronic inflammation. Here, an off‐the‐shelf artificial macrophage (artM) assembled by M2 macrophages‐derived lysate proteins‐loaded poly (lactic‐co‐glycolic acid) (PLGA) microspheres coated by macrophage cell membrane is developed. The synthetic artM fabricated in batches maintains its bioactivity with long‐term cryostorage. Significantly, artM recapitulates the essential inflammation‐regulatory and proregenerative characteristics of endogenous macrophages, including initiating M2 macrophage polarization, resolving excessive inflammation by releasing anti‐inflammatory cytokines and growth factors, neutralizing endotoxins and proinflammatory cytokines, augmenting T‐helper 2 (TH2) immune response, and coordinating cell migration and proliferation. In mouse model of deep tissue pressure injury (DTPI), the artM induces tissue regeneration by modulating the inflammatory microenvironment, promoting angiogenesis, reducing scar deposition, and accelerating the renewal of skin appendages. Depletion of macrophages in mice with skin ulcers highlights the immunomodulatory and proangiogenic functions of artM as effective as autogenous macrophages. Collectively, the engineered artM represents a cell‐free, proreparative alternative to immune cell therapy in chronic wound management.
- Open Access
- 17 April 2025
- Published by SAGE Publications in Dose-Response
- Vol. 23 (2)
Alterations of DNA Repair and Immune Infiltration in Radiation-Induced Intestinal Injury
Objectives: The intestine exhibits high radiosensitivity and is susceptible to damage during radiotherapy for abdominal or pelvic tumors, especially at radiation doses exceeding 5 Gy, which can lead to severe gastrointestinal complications. This study aims to elucidate the mechanisms of DNA repair and immune responses in radiation-induced intestinal injury, with the goal of enhancing radiotherapy efficacy. Methods: We employed weighted correlation network analysis (WGCNA) to analyze RNA sequencing data from intestinal tissues collected at various time points following irradiation, as well as from mice with targeted disruption of the NFE2-like bZIP transcription factor 2 (Nrf2) gene and their wild-type counterparts. Results: Our analysis revealed enhanced DNA repair capacity and attenuated immune response 3.5 days after irradiation. Histone variants and ribosomal proteins were identified as potential contributors to DNA repair processes. We also constructed a competing endogenous RNAs (ceRNA) network including genes from both the DNA repair and immune modules and identified Akr1b8, Gsta3, and Nqo1 as radiation-effect genes regulated by Nrf2. Conclusions: These findings provide valuable insights into the molecular mechanisms of radiation-induced intestinal injury and suggest potential targets for protecting normal intestinal tissue during radiotherapy. This knowledge may contribute to improved treatment outcomes and enhanced patient well-being.
- 17 April 2025
- Published by SAGE Publications in Dose-Response
- Vol. 23 (2)
Open AccessAlterations of DNA Repair and Immune Infiltration in Radiation-Induced Intestinal Injury
Objectives: The intestine exhibits high radiosensitivity and is susceptible to damage during radiotherapy for abdominal or pelvic tumors, especially at radiation doses exceeding 5 Gy, which can lead to severe gastrointestinal complications. This study aims to elucidate the mechanisms of DNA repair and immune responses in radiation-induced intestinal injury, with the goal of enhancing radiotherapy efficacy. Methods: We employed weighted correlation network analysis (WGCNA) to analyze RNA sequencing data from intestinal tissues collected at various time points following irradiation, as well as from mice with targeted disruption of the NFE2-like bZIP transcription factor 2 (Nrf2) gene and their wild-type counterparts. Results: Our analysis revealed enhanced DNA repair capacity and attenuated immune response 3.5 days after irradiation. Histone variants and ribosomal proteins were identified as potential contributors to DNA repair processes. We also constructed a competing endogenous RNAs (ceRNA) network including genes from both the DNA repair and immune modules and identified Akr1b8, Gsta3, and Nqo1 as radiation-effect genes regulated by Nrf2. Conclusions: These findings provide valuable insights into the molecular mechanisms of radiation-induced intestinal injury and suggest potential targets for protecting normal intestinal tissue during radiotherapy. This knowledge may contribute to improved treatment outcomes and enhanced patient well-being.
- Open Access
- 1 April 2025
- Published by SAGE Publications in Dose-Response
- Vol. 23 (2)
Exosome-Based Liquid Biopsy in Early Screening and Diagnosis of Cancers
Background: Liquid biopsy, analyzing the expression and variation of circulating tumor cell (CTC) or circulating tumor nucleic acid genes in peripheral blood, can obtain the information of tumorigenesis, metastasis and treatment, which has a potentially broader and complementary applications in the precision cancer medicine. Small vesicles, like exosomes which belongs to extracellular vesicles (EVs), which released by living cells into the vicinal surrounding biofluids, especially cells from carcinoma. Tumor-derived materials were contained by exosomes, totally including proteins, nucleic acid genes, and lipid, etcetera for instance metabolites. Besides, molecules which were synchronously belongings and carried on exosomal surface can tolerable provides crucial clues regarding their origin. Thus, classified the types of vesicles and enrich features from tissue-specific sources become presumably achieved. Therefore, exosomes and other EVs have emerged as a liquid biopsy platform for early screening and diagnosis of cancers, which constantaneously carry-over multitudinous surface molecules also throw clues regarding their origin. It is feasible to sort vesicles types, intake with approach channel to enrich the characteristics from tissue-specific origin. Based on the property that exosomes are remarkably stable in body fluids, which can amenity gathered in plasma or urine, it can be used for meticulous clinical evaluation particularly in the early stages of carcinoma. Therefore, exosomes have aroused immense interest in the study of biomarkers. Conclusions and Perspectives: This review aims to summarize the potential exosomal biomarkers especially exosomal miRNAs for exosome-based liquid biopsy in early screening and diagnostic of cancers, including lung cancer, breast cancer (BC), kidney cancer, prostate cancer (PCa), colorectal cancer (CRC), and summarizes the traditional and novel technologies for isolating exosomes and for detecting exosomal-based biomarkers, including exosomal proteins and exosomal nucleic acids. Finally, the limitations and prospects of exosome-based liquid biopsy in the early screening and diagnosis of cancers were discussed briefly.
- 1 April 2025
- Published by SAGE Publications in Dose-Response
- Vol. 23 (2)
Open AccessExosome-Based Liquid Biopsy in Early Screening and Diagnosis of Cancers
Background: Liquid biopsy, analyzing the expression and variation of circulating tumor cell (CTC) or circulating tumor nucleic acid genes in peripheral blood, can obtain the information of tumorigenesis, metastasis and treatment, which has a potentially broader and complementary applications in the precision cancer medicine. Small vesicles, like exosomes which belongs to extracellular vesicles (EVs), which released by living cells into the vicinal surrounding biofluids, especially cells from carcinoma. Tumor-derived materials were contained by exosomes, totally including proteins, nucleic acid genes, and lipid, etcetera for instance metabolites. Besides, molecules which were synchronously belongings and carried on exosomal surface can tolerable provides crucial clues regarding their origin. Thus, classified the types of vesicles and enrich features from tissue-specific sources become presumably achieved. Therefore, exosomes and other EVs have emerged as a liquid biopsy platform for early screening and diagnosis of cancers, which constantaneously carry-over multitudinous surface molecules also throw clues regarding their origin. It is feasible to sort vesicles types, intake with approach channel to enrich the characteristics from tissue-specific origin. Based on the property that exosomes are remarkably stable in body fluids, which can amenity gathered in plasma or urine, it can be used for meticulous clinical evaluation particularly in the early stages of carcinoma. Therefore, exosomes have aroused immense interest in the study of biomarkers. Conclusions and Perspectives: This review aims to summarize the potential exosomal biomarkers especially exosomal miRNAs for exosome-based liquid biopsy in early screening and diagnostic of cancers, including lung cancer, breast cancer (BC), kidney cancer, prostate cancer (PCa), colorectal cancer (CRC), and summarizes the traditional and novel technologies for isolating exosomes and for detecting exosomal-based biomarkers, including exosomal proteins and exosomal nucleic acids. Finally, the limitations and prospects of exosome-based liquid biopsy in the early screening and diagnosis of cancers were discussed briefly.
- Open Access
- 8 January 2025
- Published by SAGE Publications in Cell Transplantation
- Vol. 34
Mesenchymal Stem Cell-Derived Extracellular Vesicles for Regenerative Applications and Radiotherapy
Tissue repair is an extremely crucial part of clinical treatment. During the course of disease treatment, surgery, chemotherapy, and radiotherapy cause tissue damage. On the other hand, Normal tissue from accidental or therapeutic exposure to high-dose radiation can cause severe tissue damage. There is an urgent need for developing medical countermeasures against radiation injury for tissue repair. Tissue repair involves the regeneration, proliferation, differentiation, and migration of tissue cells; imbalance of local tissue homeostasis, progressive chronic inflammation; decreased cell activity and stem cell function; and wound healing. Although many clinical treatments are currently available for tissue repair, they are expensive. The long recovery time and some unavoidable complications such as cell damage and the inflammatory reaction caused by radiotherapy have led to unsatisfactory results. Extracellular vesicles (EVs) derived from mesenchymal stem cells (MSCs) have similar tissue repair functions as MSCs. In tissue damage, EVs can be used as an alternative to stem cell therapy, thereby avoiding related complications such as immunological rejection. EVs play a major role in regulating tissue damage, anti-inflammation, pro-proliferation, and immune response, thus providing a diversified and efficient solution for the repair of disease- and radiotherapy-induced tissue damage. This article reviews the research progress of mesenchymal stem cell-derived EVs in promoting the repair of tissue including heart, lung, liver, intestine, skin, blood system, central nervous system, and tissue damage caused by radiotherapy, thereby aiming to offer new directions and ideas for the radiotherapy and regenerative applications.
- 8 January 2025
- Published by SAGE Publications in Cell Transplantation
- Vol. 34
Open AccessMesenchymal Stem Cell-Derived Extracellular Vesicles for Regenerative Applications and Radiotherapy
Tissue repair is an extremely crucial part of clinical treatment. During the course of disease treatment, surgery, chemotherapy, and radiotherapy cause tissue damage. On the other hand, Normal tissue from accidental or therapeutic exposure to high-dose radiation can cause severe tissue damage. There is an urgent need for developing medical countermeasures against radiation injury for tissue repair. Tissue repair involves the regeneration, proliferation, differentiation, and migration of tissue cells; imbalance of local tissue homeostasis, progressive chronic inflammation; decreased cell activity and stem cell function; and wound healing. Although many clinical treatments are currently available for tissue repair, they are expensive. The long recovery time and some unavoidable complications such as cell damage and the inflammatory reaction caused by radiotherapy have led to unsatisfactory results. Extracellular vesicles (EVs) derived from mesenchymal stem cells (MSCs) have similar tissue repair functions as MSCs. In tissue damage, EVs can be used as an alternative to stem cell therapy, thereby avoiding related complications such as immunological rejection. EVs play a major role in regulating tissue damage, anti-inflammation, pro-proliferation, and immune response, thus providing a diversified and efficient solution for the repair of disease- and radiotherapy-induced tissue damage. This article reviews the research progress of mesenchymal stem cell-derived EVs in promoting the repair of tissue including heart, lung, liver, intestine, skin, blood system, central nervous system, and tissue damage caused by radiotherapy, thereby aiming to offer new directions and ideas for the radiotherapy and regenerative applications.